Structural basis for the regulation of tubulin by vinblastine

被引:581
作者
Gigant, B
Wang, CG
Ravelli, RBG
Roussi, F
Steinmetz, MO
Curmi, PA
Sobel, A
Knossow, M
机构
[1] Lab Enzymol & Biochim Struct, CNRS, UPR 9063, F-91198 Gif Sur Yvette, France
[2] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble, France
[3] CNRS, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France
[4] Paul Scherrer Inst, CH-5232 Villigen, Switzerland
[5] Inst Fer Moulin, UPMC, INSERM, U706, F-75005 Paris, France
关键词
D O I
10.1038/nature03566
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Vinblastine is one of several tubulin-targeting Vinca alkaloids that have been responsible for many chemotherapeutic successes since their introduction in the clinic as antitumour drugs(1). In contrast with the two other classes of small tubulin-binding molecules (Taxol(2) and colchicine(3)), the binding site of vinblastine is largely unknown and the molecular mechanism of this drug has remained elusive. Here we report the X-ray structure of vinblastine bound to tubulin in a complex with the RB3 protein stathmin-like domain (RB3-SLD). Vinblastine introduces a wedge at the interface of two tubulin molecules and thus interferes with tubulin assembly. Together with electron microscopical and biochemical data, the structure explains vinblastine-induced tubulin self-association into spiral aggregates at the expense of microtubule growth(4). It also shows that vinblastine and the amino-terminal part of RB3-SLD binding sites share a hydrophobic groove on the alpha-tubulin surface that is located at an intermolecular contact in microtubules. This is an attractive target for drugs designed to perturb microtubule dynamics by interfacial interference, for which tubulin seems ideally suited because of its propensity to self-associate.
引用
收藏
页码:519 / 522
页数:4
相关论文
共 30 条
[1]   Crystal structure of vinblastine [J].
Bau, R ;
Jin, KK .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 2000, (13) :2079-2082
[2]   Stathmin family proteins display specific molecular and tubulin binding properties [J].
Charbaut, E ;
Curmi, PA ;
Ozon, S ;
Lachkar, S ;
Redeker, V ;
Sobel, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (19) :16146-16154
[3]   X-ray-induced debromination of nucleic acids at the BrK absorption edge and implications for MAD phasing [J].
Ennifar, E ;
Carpentier, P ;
Ferrer, JL ;
Walter, P ;
Dumas, P .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 :1262-1268
[4]   The 4 Å X-ray structure of a tubulin:stathmin-like domain complex [J].
Gigant, B ;
Curmi, PA ;
Martin-Barbey, C ;
Charbaut, E ;
Lachkar, S ;
Lebeau, L ;
Siavoshian, S ;
Sobel, A ;
Knossow, M .
CELL, 2000, 102 (06) :809-816
[5]  
HASKINS KM, 1981, J CELL SCI, V47, P237
[6]   INTERACTIONS OF THE CATHARANTHUS (VINCA) ALKALOIDS WITH TUBULIN AND MICROTUBULES [J].
HIMES, RH .
PHARMACOLOGY & THERAPEUTICS, 1991, 51 (02) :257-267
[7]   Microtubules as a target for anticancer drugs [J].
Jordan, MA ;
Wilson, L .
NATURE REVIEWS CANCER, 2004, 4 (04) :253-265
[8]  
JORDAN MA, 1991, CANCER RES, V51, P2212
[9]   Vinca alkaloid-induced tubulin spiral formation correlates with cytotoxicity in the leukemic L1210 cell line [J].
Lobert, S ;
Fahy, J ;
Hill, BT ;
Duflos, A ;
Etievant, C ;
Correia, JJ .
BIOCHEMISTRY, 2000, 39 (39) :12053-12062
[10]   Localization of the antimitotic peptide and depsipeptide binding site on β-tubulin [J].
Mitra, A ;
Sept, D .
BIOCHEMISTRY, 2004, 43 (44) :13955-13962